Aloe Vera for Diabetes: Evidence Does Not Support Use as Treatment

Aloe vera is not a validated treatment for diabetes mellitus. Despite widespread marketing claims, current evidence is insufficient, inconsistent, and low-quality to recommend it for glycemic control.

Evidence Summary

  • Animal studies: Some show hypoglycemic effects (phytosterols, glucomannan, antioxidant activity).
  • Human trials: Few, small (n<100), short-term, heterogeneous preparations (gel, juice, extract), high risk of bias. Meta-analyses conclude "promising but inconclusive."
  • No standardized dose, formulation, or purity. Commercial products vary wildly; contamination (aloin—laxative, nephrotoxic) is a concern.

Risks

  • Hypoglycemia if combined with glucose-lowering meds (unpredictable potentiation).
  • Electrolyte imbalance (diarrhea from anthraquinones/aloin).
  • Drug interactions: CYP450 modulation; may affect metformin, warfarin, digoxin.
  • Acute hepatitis reported (rare, idiosyncratic).

Guideline Position

  • ADA, EASD, NICE: Do not recommend aloe vera for diabetes management.
  • Classified as dietary supplement (DSHEA)—not FDA-approved for any disease.

Patient Advice

  • Do not replace prescribed therapy.
  • If using, inform clinician; monitor glucose closely.
  • Choose USP/NSF certified products; avoid whole-leaf (aloin).
  • Focus on evidence-based lifestyle: diet, exercise, weight management, medication adherence.

Diabetes - Related Articles